BIOTECH ACQUISITION COMPANY Stock or Unit Option Plan Expense
BIOTECH ACQUISITION COMPANY reported Stock or Unit Option Plan Expense of $520.32 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:StockOptionPlanExpense · last filed 2022-03-08
- BIOTECH ACQUISITION COMPANY stock or unit option plan expense for the quarter ending 2021-12-31 was $0.00.
- BIOTECH ACQUISITION COMPANY stock or unit option plan expense for the quarter ending 2021-09-30 was $0.00.
- BIOTECH ACQUISITION COMPANY stock or unit option plan expense for the quarter ending 2021-06-30 was $0.00.
- BIOTECH ACQUISITION COMPANY stock or unit option plan expense for the quarter ending 2021-03-31 was $520.32K.
- BIOTECH ACQUISITION COMPANY stock or unit option plan expense for fiscal 2021 was $520.32K.
| Period end | Stock or Unit Option Plan Expense 3 month | Stock or Unit Option Plan Expense 6 month | Stock or Unit Option Plan Expense 9 month | Stock or Unit Option Plan Expense 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $0.00 derived: sum of 2 quarters · filed 2022-03-08 | $0.00 derived: sum of 3 quarters · filed 2022-03-08 | $520.32K 10-K · filed 2022-03-08 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-17 | $0.00 derived: sum of 2 quarters · filed 2021-11-17 | $520.32K 10-Q · filed 2021-11-17 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $520.32K 10-Q · filed 2021-08-11 | ||
| 2021-03-31 | $520.32K 10-Q · filed 2021-05-24 |